Wockhardt

About:

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world.

Website: http://wockhardt.com

Top Investors: Modulus Alternatives, MAPE Advisory Group

Description:

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Total Funding Amount:

970M INR

Estimated Revenue Range:

$10B+

Headquarters Location:

Mumbai, Maharashtra, India

Founded Date:

1999-01-01

Contact Email:

prems(AT)wockhardt.com

Founders:

Habil Khorakiwala

Number of Employees:

10001+

Last Funding Date:

2024-03-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai